Ferrum Bromatum

.alpha.-ketoglutaric Acid - Aconitic Acid, Cis - Adenosine Triphosphate - Alpha Lipoic Acid - Ascorbic Acid - Asian Ginseng - Barium Cation - Beet - Cerous Oxalate Nonahydrate - Coenzyme A - Cysteine - Fumaric Acid - Lactic Acid, Dl - Magnesium Carbonate - Malic Acid - Manganese Phosphate, Dibasic - Pork - Pyridoxine Hydrochloride - Riboflavin - Sodium Diethyl Oxalacetate - Sodium Pyruvate - Succinic Acid - Sus Scrofa Adrenal Gland - Thiamine Hydrochloride - Sus Scrofa Embryo -

.alpha.-ketoglutaric acid - aconitic acid, cis - adenosine triphosphate - alpha lipoic acid - ascorbic acid - asian ginseng - barium cation - beet - cerous oxalate nonahydrate - coenzyme a - cysteine - fumaric acid - lactic acid, dl - magnesium carbonate - malic acid - manganese phosphate, dibasic - pork - pyridoxine hydrochloride - riboflavin - sodium diethyl oxalacetate - sodium pyruvate - succinic acid - sus scrofa adrenal gland - thiamine hydrochloride - sus scrofa embryo -

Vitamin C [EPC]

USES For the temporary relief of symptoms related to athletic training and exertion such as: Muscle cramps Sore muscles Lack of endurance

Ferumoxytol Non-stoichiometric Magnetite

ferumoxytol non-stoichiometric magnetite

Dosage form: INJECTION. Active ingredients: FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE (510 mg/17mL). Category: DRUG FOR FURTHER PROCESSING.

Eflapegrastim-xnst

eflapegrastim-xnst

Leukocyte Growth Factor [EPC]

11 DESCRIPTION Eflapegrastim-xnst is a granulocyte colony-stimulating factor (G‑CSF) produced by covalent coupling of a human G-CSF analog (18.6 kDa) and an Fc fragment of human immunoglobulin G4 (IgG4) (49.8 kDa), both derived from recombinant E. coli , via a single 3.4 kDa polyethylene glycol linker. The recombinant G-CSF domain in eflapegrastim-xnst is a variant of human G-CSF with two serine substitutions at positions 17 and 65, and no additional N-terminal methionine.